[Pathogenesis and treatment of non-alcoholic fatty liver disease]

Ping Xie1, Xin-xi Zhou, Qin Zhang

  • 1Department of Liver Diseases, Shanghai Public Clinical Health Center, Fudan University, Shanghai 201508, China.

Insights

Reactive oxygen species (ROS) drive non-alcoholic fatty liver disease (NAFLD) pathogenesis, linked to insulin resistance (IR). Novel treatments target ROS, iron, and utilize traditional Chinese medicine for improved NAFLD management.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Biochemistry

Context:

  • Non-alcoholic fatty liver disease (NAFLD) is a growing global health concern.
  • Understanding NAFLD pathogenesis is crucial for effective clinical practice.
  • Existing literature provides a foundation for exploring NAFLD's complex mechanisms.

Purpose:

  • To analyze recent literature on NAFLD pathogenesis and treatment.
  • To identify key factors contributing to NAFLD development.
  • To evaluate evidence-based therapeutic strategies for NAFLD.

Summary:

  • Reactive oxygen species (ROS) generation is identified as the primary driver of NAFLD, intricately linked with insulin resistance (IR) in the "two-hit" model.
  • Multiple factors including leptin resistance, immune cell involvement, metabolic dysregulation, and gut microbiome imbalance contribute to NAFLD progression.
  • Effective NAFLD treatments encompass conventional approaches (IR improvement, antioxidation, lipid management) and emerging therapies (nuclear receptor modulators, iron chelation, traditional Chinese medicine).

Impact:

  • Highlights the central role of ROS in NAFLD, guiding future research.
  • Provides a comprehensive overview of contributing factors for a holistic understanding of NAFLD.
  • Informs clinical practice by validating established treatments and suggesting novel therapeutic avenues for NAFLD.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...